Compass Therapeutics, Inc. (CMPX)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
38
$151.85M held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| BlackRock, Inc. | Aug 7, 2026 | $24.71M |
| STATE STREET CORP | Aug 7, 2026 | $21.80M |
| Vanguard Capital Management | Aug 13, 2026 | $13.40M |
| MILLENNIUM MANAGEMENT LLC | Aug 14, 2026 | $10.32M |
| Ameriprise Financial, Inc. | Jul 17, 2026 | $8.45M |
CMPX's filings are public. The insight is one click away.
Scrutar's AI reads every CMPX filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze CMPX filingsNo credit cardAI reports included on the free plan
Never miss a CMPX filing.
Get an email when CMPX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 30, 2026Source: SEC EDGAR.